Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA) and Canada. This trial is
designed to show the effect of treatment with liraglutide when added to existing
rosiglitazone and metformin combination therapy and to compare it with the effects of therapy
with rosiglitazone and metformin alone.